SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories - Quaterly Results

14 Nov 2025 Evaluate
The September 2025 quarter revenue stood at Rs. 25420.30 millions, up 7.95% as compared to Rs. 23547.20 millions during the corresponding quarter last year.The Company has registered profit of Rs. 7236.60  millions for the quarter ended September 2025, a growth of 12.75%  over Rs. 6418.50 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2025 rose to 8720.50 millions as compared to 7604.80 millions of corresponding quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 25420.30 23547.20 7.95 49142.00 44816.80 9.65 88134.40 79638.50 10.67
Other Income 1013.70 1201.90 -15.66 2179.50 2262.90 -3.69 5070.60 3059.90 65.71
PBIDT 8720.50 7604.80 14.67 16091.10 14278.50 12.69 26632.60 19771.70 34.70
Interest 127.50 171.80 -25.79 255.40 382.00 -33.14 761.10 800.70 -4.95
PBDT 8593.00 7433.00 15.61 15978.60 13896.50 14.98 25871.50 18332.70 41.12
Depreciation 585.90 613.00 -4.42 1174.80 1243.60 -5.53 2836.10 2391.40 18.60
PBT 8007.10 6820.00 17.41 14803.80 12652.90 17.00 23035.40 15941.30 44.50
TAX 770.50 401.50 91.91 1344.60 777.00 73.05 2138.20 336.20 535.99
Deferred Tax -465.10 -622.30 -25.26 -984.40 -1158.00 -14.99 -1363.10 -1994.00 -31.64
PAT 7236.60 6418.50 12.75 13459.20 11875.90 13.33 20897.20 15605.10 33.91
Equity 239.10 239.10 0.00 239.10 239.10 0.00 239.10 239.10 0.00
PBIDTM(%) 34.31 32.30 6.22 32.74 31.86 2.78 30.22 24.83 21.72

Alkem Laboratories Share Price

5583.70 16.00 (0.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×